Page 68 - JCBP-2-4

Journal of Clinical and
Basic Psychosomatics Schizophrenia and metabolism

Scientific Statement. Circulation. 2005;112:2735-2752. depression and metabolic syndrome and its components:
A bidirectional two-sample Mendelian randomization
doi: 10.1161/circulationaha.105.169404
study. Transl Psychiatry. 2021;11:633.
28. Hagi K, Nosaka T, Dickinson D, et al. Association between
cardiovascular risk factors and cognitive impairment in doi: 10.1038/s41398-021-01759-z
people with schizophrenia: A systematic review and meta- 35. Dregan A, Rayner L, Davis KAS, et al. Associations between
analysis. JAMA Psychiatry. 2021;78:510-518. depression, arterial stiffness, and metabolic syndrome
doi: 10.1001/jamapsychiatry.2021.0015 among adults in the UK biobank population study:
A mediation analysis. JAMA Psychiatry. 2020;77:598-606.
29. Harrison S, Couture P, Lamarche B. Diet quality, saturated
fat and metabolic syndrome. Nutrients. 2020;12:3232. doi: 10.1001/jamapsychiatry.2019.4712
doi: 10.3390/nu12113232 36. Wang J, Li L, Zhang Z, et al. Extracellular vesicles mediate the
communication of adipose tissue with brain and promote
30. Hsu CN, Hou CY, Hsu WH, Tain YL. Early-life origins of cognitive impairment associated with insulin resistance. Cell
metabolic syndrome: Mechanisms and preventive aspects. Metab. 2022;34:1264-1279.e8.
Int J Mol Sci. 2021;22:11872.
doi: 10.1016/j.cmet.2022.08.004
doi: 10.3390/ijms222111872
37. Wajngarten M, Silva GS. Hypertension and stroke: Update
31. Carli M, Kolachalam S, Longoni B, et al. Atypical on treatment. Eur Cardiol. 2019;14:111-115.
antipsychotics and metabolic syndrome: From molecular
mechanisms to clinical differences. Pharmaceuticals (Basel). doi: 10.15420/ecr.2019.11.1
2021;14:238. 38. Anjum S, Bathla M, Panchal S, Singh GP, Singh M. Metabolic
doi: 10.3390/ph14030238 syndrome in drug naïve schizophrenic patients. Diabetes
Metab Syndr. 2018;12:135-140.
32. Citrome L, Holt RI, Walker DJ, Hoffmann VP. Weight gain
and changes in metabolic variables following olanzapine doi: 10.1016/j.dsx.2017.11.006
treatment in schizophrenia and bipolar disorder. Clin Drug 39. Enez Darcin A, Yalcin Cavus S, Dilbaz N, Kaya H, Dogan E.
Investig. 2011;31:455-482. Metabolic syndrome in drug-naïve and drug-free patients
doi: 10.2165/11589060-000000000-00000 with schizophrenia and in their siblings. Schizophr Res.
2015;166:201-206.
33. De Hert M, Schreurs V, Sweers K, et al. Typical and atypical
antipsychotics differentially affect long-term incidence rates doi: 10.1016/j.schres.2015.05.004
of the metabolic syndrome in first-episode patients with 40. Chen DC, Du XD, Yin GZ, et al. Impaired glucose tolerance
schizophrenia: A retrospective chart review. Schizophr Res. in first-episode drug-naïve patients with schizophrenia:
2008;101:295-303.
Relationships with clinical phenotypes and cognitive
doi: 10.1016/j.schres.2008.01.028 deficits. Psychol Med. 2016;46:3219-3230.
34. Zhang M, Chen J, Yin Z, Peng L. The association between doi: 10.1017/s0033291716001902

Volume 2 Issue 4 (2024) 12 doi: 10.36922/jcbp.4238